French clinical practice guidelines for Moyamoya angiopathy
2 Pediatric Neurology Department, Necker–Enfants Malades H ospital, APHP, Paris, France
3 Service de neurochirurgie pédiatrique [CHU Necker]
4 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
5 PhIND - Physiopathologie et imagerie des troubles neurologiques
6 Service de Neurologie [CHU Caen]
7 Service de Neurochirurgie [CHU Rouen]
8 HUS - Hôpitaux Universitaires de Strasbourg
9 UPD5 - Université Paris Descartes - Paris 5
10 SU - Sorbonne Université
11 CHU Saint-Antoine [AP-HP]
12 Service de neurologie
13 CHU Pitié-Salpêtrière [AP-HP]
14 University of Saida
15 Service de radiologie [CHU Necker]
16 Service de Rééducation des pathologies neurologiques acquises de l'enfant [Hôpitaux de Saint Maurice]
17 LIB - Laboratoire d'Imagerie Biomédicale [Paris]
18 LIB - Laboratoire d'Imagerie Biomédicale [Paris]
19 HUG - Hôpitaux Universitaires de Genève = University Hospital of Geneva [Genève]
20 Service de Neurochirurgie [CHRU Besançon]
21 Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
22 U1161 / UMR_S 1161 - Génétique et Physiopathologie des Maladies Cérébro-Vasculaires
23 AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
- Fonction : Auteur
- Fonction : Auteur
- PersonId : 1100178
- IdHAL : thomas-blauwblomme
- ORCID : 0000-0003-4076-9642
- Fonction : Auteur
- Fonction : Auteur
- Fonction : Auteur
- Fonction : Auteur
- Fonction : Auteur
- Fonction : Auteur
- Fonction : Auteur
- PersonId : 1379259
- ORCID : 0000-0002-3039-1677
- IdRef : 060854448
Résumé
We evaluated the cognitive status of visually impaired patients referred to low vision rehabilitation (LVR) based on a standard cognitive battery and a new evaluation tool, named the COGEVIS, which can be used to assess patients with severe visual deficits. We studied patients aged 60 and above, referred to the LVR Hospital in Paris. Neurological and cognitive evaluations were performed in an expert memory center. Thirty-eight individuals, 17 women and 21 men with a mean age of 70.3 ± 1.3 years and a mean visual acuity of 0.12 ± 0.02, were recruited over a one-year period. Sixty-three percent of participants had normal cognitive status. Cognitive impairment was diagnosed in 37.5% of participants. The COGEVIS score cutoff point to screen for cognitive impairment was 24 (maximum score of 30) with a sensitivity of 66.7% and a specificity of 95%. Evaluation following 4 months of visual rehabilitation showed an improvement of Instrumental Activities of Daily Living ( p = 0.004 ), National Eye Institute Visual Functioning Questionnaire ( p = 0.035 ), and Montgomery–Åsberg Depression Rating Scale ( p = 0.037 ). This study introduces a new short test to screen for cognitive impairment in visually impaired patients.